Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in colorectal cancer cells
Cell Biology International · 2023
DOI: 10.1002/cbin.12060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, 2023. Verfasst von Adriana S Gehren und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Oncobiology Program, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: NF-kappa B, Colorectal Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.
Abstract (Originalsprache)
The activation of the nuclear factor‐κB (NF‐κB) pathway has been associated with the development and progression of colorectal cancer (CRC). Parthenolide (PTL), a well‐known inhibitor of the NF‐κB pathway, has emerged as an alternative treatment. However, whether PTL activity is tumor cell‐specific and dependent on the mutational background has not been defined. This study investigated the antitumor role of PTL after tumor necrosis factor‐α (TNF‐α) stimulation in various CRC cell lines with different mutational statuses of TP53 . We observed that CRC cells displayed different patterns of basal p‐IκBα levels; PTL reduced cell viability according to p‐IκBα levels and p‐IκBα levels varied among the cell lines according to the time of TNF‐α stimulation. High concentrations of PTL reduced more effectively p‐IκBα levels than low doses of PTL. However, PTL increased total IκBα levels in Caco‐2 and HT‐29 cells. In addition, PTL treatment downregulated p‐p65 levels in HT‐29 and HCT‐116 cells stimulated by TNF‐α in a dose‐dependent manner. Moreover, PTL induced cell death via apoptosis and reduced the proliferation rate of TNF‐α‐treated HT‐29 cells. Finally, PTL downregulated the messenger RNA levels of interleukin‐1β, a downstream cytokine of NF‐κB, reverted the E‐cadherin‐mediated disorganization of cell–cell contacts, and decreased the invasion of HT‐29 cells. Together, these results suggest a differential antitumoral activity of PTL on CRC cells with different mutational statuses of TP53 , modulating cell death, survival, and proliferation underlying the NF‐κB pathway TNF‐α‐induced. Therefore, PTL has emerged as a potential treatment for CRC in an inflammatory NF‐κB‐dependent manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cellular and Molecular Oncobiology Program, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
- Stem Cell Laboratory, Center for Bone Marrow Transplants, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Zitieren
APA
Gehren, A. S., de Souza, W. F., Sousa-Squiavinato, A. C. M., Ramos, D. A. A., Pires, B. R. B., Abdelhay, E. S. F. W., & Morgado-Diaz, J. A. (2023). Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in colorectal cancer cells. Cell Biology International. https://doi.org/10.1002/cbin.12060
Vancouver
Gehren AS, de Souza WF, Sousa-Squiavinato ACM, Ramos DAA, Pires BRB, Abdelhay ESFW, et al. Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in colorectal cancer cells. Cell Biology International. 2023. doi:10.1002/cbin.12060
BibTeX
@article{Gehren2023,
author = {Gehren, Adriana S and de Souza, Waldemir F and Sousa-Squiavinato, Annie C M and Ramos, Diego A A and Pires, Bruno R B and Abdelhay, Eliana S F W and Morgado-Diaz, Jose A},
title = {Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in colorectal cancer cells},
journal = {Cell Biology International},
year = {2023},
doi = {10.1002/cbin.12060}
}
EUVIMED